Browse > Article
http://dx.doi.org/10.5808/GI.2009.7.2.057

Association between Single Nucleotide Polymorphisms of the Fibrinogen Alpha Chain (FGA) Gene and Type 2 Diabetes Mellitus in the Korean Population  

Hwang, Joo-Yeon (Center for Genome Science, National Institute of Health)
Ryu, Min-Hyung (Center for Genome Science, National Institute of Health)
Go, Min-Jin (Center for Genome Science, National Institute of Health)
Oh, Berm-Seok (Department of Biomedical Engineering, School of Medicine, Kyung Hee University)
Cho, Yoon-Shin (Center for Genome Science, National Institute of Health)
Publication Information
Genomics & Informatics / v.7, no.2, 2009 , pp. 57-64 More about this Journal
Abstract
Fibrinogen alpha chain (FGA), a subunit of fibrinogen, might be a potential player for type 2 diabetes mellitus (T2DM), since the plasma levels of fibrinogen is known to be related to the incidence of T2DM. To elucidate the potential role of FGA in T2DM, we investigated whether FGA genetic variations are relevant in T2DM in the Korean population. Seven FGA single nucleotide polymorphisms (SNPs) were genotyped in Ansung and Ansan cohorts (474 T2DM subjects and 470 normal controls) in Korea. The association between SNPs and T2DM was determined by logistic regression analysis. Genetic relevance of SNPs to T2DM-related phenotypes was investigated by multiple linear regression analysis. Statistical analysis revealed that among seven FGA SNPs, significant associations with T2DM were observed in FGA rs2070011 (p=0.013-0.034, OR=0.72${\sim}$0.79), rs6050 (p=0.026${\sim}$0.048, OR=1.24${\sim}$1.37), and rs2070022 (p=0.016${\sim}$0.039, OR=0.70${\sim}$0.72). Two SNPs, rs2070011 and rs6050, also showed significant association with T2DM-related phenotypes such as triglyceride (p=0.005${\sim}$0.011 for rs2070011 and p=0.003${\sim}$0.008 for rs6050), total cholesterol (p=0.01 for rs2070011 and p=0.024 for rs6050) and fasting glucose (p=0.035${\sim}$0.036 for rs2070011 and p=0.048 for rs6050) in 470 normal controls. Our association study implies that FGA might be an important genetic factor in T2DM pathogenesis in the Korean population by affecting plasma lipid and glucose levels.
Keywords
association; FGA; single nucleotide polymorphism (SNP); T2DM;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Barrett, J.C., Fry, B., Maller, J., and Daly, M.J. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265   DOI   ScienceOn
2 Engstrom, G., Hedblad, B., Janzon, L., and Lindgarde, F. (2007). Long-term change in cholesterol in relation to inflammation- sensitive plasma proteins: a longitudinal study. Ann. Epidemiol. 17, 57-63   DOI   ScienceOn
3 Friedlander, Y., Kark, J.D., Sinnreich, R., Basso, F., and Humphries, S.E. (2003). Combined segregation and linkage analysis of fibrinogen variability in Israeli families: evidence for two quantitative-trait loci, one of which is linked to a functional variant (-58G ＞ A) in the promoter of the alpha-fibrinogen gene. Ann. Hum. Genet. 67, 228-241   DOI   ScienceOn
4 Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91   DOI   PUBMED   ScienceOn
5 Hurd, C.O., Cheetham-Wilkinson, C., and Ouwehand, W. (2000). HPA-1, -2 and -3 genotyping using the Taqman?reaction. Transfus. Med. 10, 326
6 Kannel, W.B., D'Agostino, R.B., Wilson, P.W., Belanger, A.J., and Gagnon, D.R. (1990). Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience. Am. Heart J. 120, 672-676   DOI   ScienceOn
7 Nickerson, D.A., Tobe, V.O., and Taylor, S.L. (1997). Poly-Phred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res. 25, 2745-275   DOI   ScienceOn
8 Ramensky, V., Bork, P., and Sunyaev, S. (2002). Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894-3900   DOI   ScienceOn
9 Rozen, S., and Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132, 365-386   DOI
10 Mosesson, M.W., Siebenlist, K.R., and Meh, D.A. (2001). The structure and biological features of fibrinogen and fibrin. Ann. N. Y. Acad. Sci. 936, 11-30   DOI   PUBMED
11 Pickup, J.C. (2006). Inflammatory markers and type 2 diabetes. Diabetes Technol. Ther. 8, 1-6   DOI   ScienceOn
12 McMillan, D.E. (1989). Increased levels of acute-phase serum proteins in diabetes. Metabolism 38, 1042-1046   DOI   PUBMED   ScienceOn
13 Hotamisligil, G.S., and Spiegelman, B.M. (1994). Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 43, 1271-1278   DOI   ScienceOn
14 Pickup, J.C., and Crook, M.A. (1998). Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41, 1241-1248   DOI   ScienceOn
15 Ganda, O.P., and Arkin, C.F. (1992). Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care 15, 1245-1250   DOI   ScienceOn
16 Hsueh, W.A., Lyon, C.J., and Quinones, M.J. (2004). Insulin resistance and the endothelium. Am. J. Med. 117, 109-117   DOI   ScienceOn
17 Roy, S., Overton, O., and Redman, C. (1994). Overexpression of any fibrinogen chain by Hep G2 cells specifically elevates the expression of the other two chains. J. Biol. Chem. 269, 691-695   PUBMED
18 Jonsson, A., and Wales, J.K. (1976). Blood glycoprotein levels in diabetes mellitus. Diabetologia 12, 245-250   DOI   ScienceOn
19 Imperatore, G., Riccardi, G., Iovine, C., Rivellese, A.A., and Vaccaro, O. (1998). Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care 21, 649-654   DOI   ScienceOn
20 Grimble, R.F. (2002). Infammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5, 551-559   DOI   ScienceOn
21 Sakkinen, P.A., Wahl, P., Cushman, M., Lewis, M.R., and Tracy, R.P. (2000). Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am. J. Epidemiol. 152, 897-907   DOI   ScienceOn
22 Hamsten, A., Iselius, L., de Faire, U., and Blomback, M. (1987). Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet. 2, 988-991   DOI   ScienceOn
23 Kamath, S., and Lip, G.Y. (2003). Fibrinogen: biochemistry, epidemiology and determinants. Qjm 96, 711-729   DOI   ScienceOn
24 Dunn, E.J., and Ariens, R.A. (2004). Fibrinogen and fibrin clot structure in diabetes. Herz 29, 470-479   DOI
25 Heinrich, J., Funke, H., Rust, S., Schulte, H., Schonfeld, R., and Kohler, E. (1995). Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb. Res. 77, 209-215   DOI   ScienceOn
26 Landin, K., Tengborn, L., and Smith, U. (1990). Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J. Intern. Med. 227, 273-278   DOI   ScienceOn
27 Pauline, C., Ng, P.C., and Henikoff, S. (2002). Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436-446   DOI   ScienceOn
28 Festa, A., D'Agostino, R.J., Tracy, R.P., and Haffner, S.M. (2002). Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137   DOI   ScienceOn
29 Manolio, T.A., Cushman, M., Gottdiener, J.S., Dobs, A., Kuller, L.H., and Kronmal, R.A. (2004). Predictors of falling cholesterol levels in older adults: the Cardiovascular Health Study. Ann. Epidemiol. 14, 325-331   DOI   ScienceOn
30 Redman, C.M., and Xia, H. (2001). Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion. Ann. N. Y. Acad. Sci. 936, 480-495   DOI   PUBMED
31 Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830   DOI   PUBMED
32 Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M.M., and Ristow, M. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. Technol. Ther. 52, 812-817   DOI   ScienceOn
33 Ernst, E., and Resch, K.L. (1993). Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118, 956-963   DOI   PUBMED   ScienceOn
34 Maumus, S., Marie, B., Vincent-Viry, M., Siest, G., and Visvikis-Siest, S. (2007). Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB -455 G/A polymorphism. Atherosclerosis 191, 369-376   DOI   ScienceOn